We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+563.35%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
-$247K
Cap. Flow %
-0%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
485
Reduced
534
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$45.3M
2
MDVN
MEDIVATION, INC.
MDVN
+$33.2M
3
DHR icon
Danaher
DHR
+$28.3M
4
FLTX
Fleetmatics Group PLC
FLTX
+$25.2M
5
HCSG icon
Healthcare Services Group
HCSG
+$24.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDP icon
476
Invesco Dorsey Wright Momentum ETF
PDP
$1.49B
$2.17M 0.02%
51,095
+2,120
+4% +$90.6K
WEC icon
477
WEC Energy
WEC
$35.2B
$2.15M 0.02%
35,970
+711
+2% +$44.4K
EXC icon
478
CALL
Exelon
EXC
$46.7B
$2.11M 0.02%
+88,887
New +$2.23M
CSRA
479
DELISTED
CSRA Inc.
CSRA
$2.1M 0.02%
78,213
-24,564
-24% -$634K
HSY icon
480
Hershey
HSY
$36.8B
$2.1M 0.02%
21,957
-768
-3% -$81.3K
IBB icon
481
iShares Biotechnology ETF
IBB
$9.53B
$2.08M 0.02%
21,591
-11,340
-34% -$1.08M
MGK icon
482
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
$2.08M 0.02%
118,990
+6,870
+6% +$119K
SRE icon
483
Sempra
SRE
$55.1B
$2.07M 0.02%
38,666
-740
-2% -$40.3K
EEMV icon
484
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.52B
$2.07M 0.02%
38,221
-380
-1% -$20.3K
DE icon
485
Deere & Co
DE
$166B
$2.04M 0.02%
23,840
+227
+1% +$18.6K
HSIC icon
486
Henry Schein
HSIC
$9.83B
$2.03M 0.02%
31,801
+1,022
+3% +$67.8K
AIRM
487
DELISTED
Air Methods Corp
AIRM
$2.02M 0.02%
64,281
-2,991
-4% -$102K
APPF icon
488
AppFolio
APPF
$6.87B
$2.02M 0.02%
+103,915
New +$1.81M
VTR icon
489
Ventas
VTR
$47.3B
$2.02M 0.02%
28,595
-41,126
-59% -$2.99M
MPLX icon
490
MPLX
MPLX
$61.3B
$2.02M 0.02%
59,593
– –
MCK icon
491
McKesson
MCK
$102B
$2.01M 0.02%
12,042
+536
+5% +$99.9K
IWP icon
492
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$1.98M 0.02%
40,678
+2,232
+6% +$108K
MACK
493
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.96M 0.02%
39,287
+2,828
+8% +$117K
EPAM icon
494
EPAM Systems
EPAM
$4.86B
$1.96M 0.02%
28,296
+7,989
+39% +$543K
TWX
495
DELISTED
Time Warner Inc
TWX
$1.95M 0.02%
24,517
+4,348
+22% +$340K
ALXN
496
DELISTED
Alexion Pharmaceuticals
ALXN
$1.95M 0.02%
15,900
+2,069
+15% +$266K
HSTM icon
497
HealthStream
HSTM
$822M
$1.95M 0.02%
70,560
+145
+0.2% +$3.75K
GLOB icon
498
Globant
GLOB
$1.61B
$1.94M 0.02%
45,979
+1,025
+2% +$41.9K
NEO icon
499
NeoGenomics
NEO
$2B
$1.9M 0.02%
230,891
+63,253
+38% +$531K
CBRE icon
500
CBRE Group
CBRE
$42.7B
$1.86M 0.02%
66,368
+24,302
+58% +$693K
18 19
20
21 22

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 485 increased, 534 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.